Cargando…
Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: report of a case
BACKGROUND: BRAF and MEK are component of the MAPK/ERK pathway and inhibitors of these proteins have significantly improved the outcome of metastatic melanoma. We report for the first time two sequential episodes of pneumonitis presumably induced by trametinib (a MEK inhibitor) and vemurafenib (a BR...
Autores principales: | Giraud, Violaine, Longvert, Christine, Houlle-Crepin, Solène, Danel, Claire, Labrune, Sylvie, Camus, Philippe, Saiag, Philippe, Chinet, Thierry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612419/ https://www.ncbi.nlm.nih.gov/pubmed/26481107 http://dx.doi.org/10.1186/s12885-015-1754-3 |
Ejemplares similares
-
Clinical factors associated with early progression and grade 3–4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab
por: Dumenil, Coraline, et al.
Publicado: (2018) -
Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration
por: Wang, Lei, et al.
Publicado: (2017) -
Feasibility of spirometry in primary care to screen for COPD: a pilot study
por: Giraud, Violaine, et al.
Publicado: (2016) -
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients
por: Dacosta-Noble, Philippine, et al.
Publicado: (2019) -
Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab
por: Ouaknine Krief, Julia, et al.
Publicado: (2019)